Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Techne (TECH) Assets Average (2016 - 2025)

Historic Assets Average for Bio-Techne (TECH) over the last 16 years, with Q4 2025 value amounting to $2.5 billion.

  • Bio-Techne's Assets Average fell 661.42% to $2.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.5 billion, marking a year-over-year decrease of 661.42%. This contributed to the annual value of $2.6 billion for FY2025, which is 151.28% down from last year.
  • Latest data reveals that Bio-Techne reported Assets Average of $2.5 billion as of Q4 2025, which was down 661.42% from $2.5 billion recorded in Q3 2025.
  • In the past 5 years, Bio-Techne's Assets Average registered a high of $2.7 billion during Q4 2023, and its lowest value of $2.1 billion during Q1 2021.
  • For the 5-year period, Bio-Techne's Assets Average averaged around $2.5 billion, with its median value being $2.5 billion (2025).
  • As far as peak fluctuations go, Bio-Techne's Assets Average soared by 1637.61% in 2023, and later tumbled by 661.42% in 2025.
  • Over the past 5 years, Bio-Techne's Assets Average (Quarter) stood at $2.3 billion in 2021, then increased by 3.04% to $2.4 billion in 2022, then grew by 16.38% to $2.7 billion in 2023, then dropped by 1.45% to $2.7 billion in 2024, then decreased by 6.61% to $2.5 billion in 2025.
  • Its Assets Average stands at $2.5 billion for Q4 2025, versus $2.5 billion for Q3 2025 and $2.6 billion for Q2 2025.